BioInformant Logo - As Featured On

About Us

Are You Managing a Stem Cell Company or Cord Blood Bank?

We can assist you with your strategic goals, because we specialize in your industry niche. BioInformant is the only company that has specifically tracked the stem cell sector since it emerged.

Because there are hematopoietic stem cells in cord blood and mesenchymal stem cells in cord tissue, we’ve also been tracking the cord blood industry since 2006.

Our leadership team comes from a bioinformatics background – the science of collecting and analyzing complex biological data such as genetic codes – and we’re trained in applying these novel data analysis techniques to the field of market research.

To date, BioInformant has been featured on prominent news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, CBS News, the California Institute of Regenerative Medicine (CIRM), and more.

Only Research Firm that Has Served the Stem Cell Market Since It Emerged

Our focus on the stem cell industry and our historical knowledge of it makes us uniquely positioned to be your source of market information.

We began tracking the stem cell industry in 2004 when only two types of stem cells were commonly discussed, adult stem cells and embryonic stem cells.

Today, researchers debate the number of stem cells in existence, as the number depends on whether stem cells are characterized functionally (e.g. neural stem cells, mesenchymal stem cells, induced pluripotent stem cells) or characterized by source tissue (e.g cord blood stem cells, dental pulp stem cells, amniotic stem cells, etc.).

What is clear is that dozens of stem cell types now exist, all representing unique opportunities for your company.

Serving Leading Biotech & Pharma Companies Worldwide

Dedicated exclusively to stem cell markets, we understand current and future product trends more intimately than any other company.

Stem Cell Companies/Organizations We Have Served

GE Biosciences
Beckman Coulter
Life Technologies
BD Biosciences
Thermo Fischer Scientific 
Corning, Inc. 
Sigma Aldrich
Teva Pharmaceuticals
WARF (Wisconsin Alumni Research Foundation) 
Novus Biologicals
Applied Stem Cell
Abcam Plc
MetaCyte Business Lab
University of Western Ontario 
California Institute of Regenerative Medicine (CIRM)
Chugai Pharmaceutical Co., Ltd.
Kaneka Corporation
DS Pharma Biomedical Co., Ltd.
New York Stem Cell Foundation (NYSCF)
Stemcell Medicine Ltd
Cell Line Genetics, Inc.
North American Research and Innovation Center
Mediware Information Systems, Inc
HealthPoint Biotherapeutics
Axol Bioscience Ltd.
Angiocrine Biosciences
ViGene Biosciences, Inc.
Optimat Limited
Tissue Culture Biologics
Progenitor Life Sciences
Boston Consulting Group
BioLife Solutions
And Many More…

Cord Blood is Richly Populated with Stem Cells

There are hematopoietic stem cells in cord blood and mesenchymal stem cells in cord tissue. There are also progenitor cells in both placental tissue and amniotic tissues.

As such, we have also have been tracking the cord blood banking industry since 2006 and are the leading cord blood research firm worldwide.

To date, we have served nearly all of the world’s leading cord blood banks, including:

Leading Cord Blood Banks We Have Served
BioInformant - Cord Blood Clients

Cells For Life Cord Blood Institute

Canadian Blood Services
CellCare Australia
Raynish Group
Cryo-Save AG
Neostem, Inc.
StemCyte, Inc.
Cord Life – Singapore
Virgin Health Bank
Insception Cord Blood Bank
California Institute of Regenerative Medicine (CIRM)
NHS Blood and Transplant (NHSBT)
New York Blood Center
Biosafe SA
Kaneka Corporation
Xytex Corporation
National Marrow Donor Program (NMDP)
The New Hope Center for Reproductive Medicine
SmartBank Italy
Till Group
Precious Cells
Health Advances (Strategy Consultants for the HealthCare Industry)
BioCells Argentina
And Many More…

Your Trusted Provider of Stem Cell Industry Data

As Featured On

To date, BioInformant has been featured on prominent news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, CBS News, the California Institute for Regenerative Medicine (CIRM), and more.

We also attend the annual World Cord Blood Conference as a strategic partner of the organizer, present stem cell market data at the virtual conference StemCell MeetUp, and are featured as a “Publisher Spotlight” on

We enjoy connecting with our clients at stem cell and cord blood industry conferences worldwide.

U.S. Based Company with Headquarters in Roseville, MN, and Washington, DC

As a U.S. based company, we are available to meet and speak with you about your questions.  Having direct contact with you allows us to clearly understand your core objectives, which are to:

  1. Make smarter decisions, faster
  2. Compete without the expense of new hires or a huge business development department
  3. Assess profitable opportunities within stem cell or cord blood markets
  4. Develop high-demand products that will bring customers to you, instead of your competition
  5. Increase revenue within your organization
  6. Minimize risk by understanding competitive threats

We track the stem cell industry continuously in real-time, so we have a unique ability to connect with about your market strengths, weaknesses, opportunities, and threats.

Currently, we are the only provider of stem cell market research offering direct support and engagement as a complimentary service.

Providing You with FREE Stem Cell and Cord Blood Market Insights

We also publish a huge amount of free content about market trends and opportunities at our blog.

Because stem cell science is rapidly evolving, there are constant events in the sector that shift industry dynamics. Often, these events are announcements of technical or scientific advancements.  Sometimes they are announcements of major industry alliances. Occasionally, they are announcements of a new industry competitor, a major milestone, or a significant funding award.

For those of us interested in stem cell and cord blood markets, tracking these shifting dynamics is of paramount importance.  We also publish current trend rate data so that you can immediately make more informed, educated decisions about the direction your company.

View the BioInformant blog now.

Our Clients Say It Best

However, you don’t have to take our word for it. Our clients say it best in their testimonials below.

“I was truly impressed by BioInformant. You can trust BioInformant to do things right and generate greater awareness of your technology. They are the go-to resource for stem cell researchers and companies looking for trustworthy stem cell business information and marketing support.”

Dr. William Frey II
Founder and Co-Director of the Alzheimer’s Research Center

“I am now truly enlightened. You are awesome! I must say it has been an absolute pleasure working with you folks. You will always get a great customer recommendation from me.”

John Jaskowiak
Vice President, Angiocrine Bioscience

“A special effort was made to render this excellent report accessible to us. The discussions that followed were very helpful and will contribute to the realization of our objective…”

Michael Pepper, MBChB, PhD, MD
Director, Institute for Cellular and Molecular Medicine
Professor, Dept. of Immunology, Faculty of Health Sciences
University of Pretoria
Johannesburg, South Africa

60-Day Money Back Guarantee To Ensure Your Satisfaction

Finally, all BioInformant products come with a 100% Money Back Guarantee.  If the strategies and tools aren’t helpful to you – we’ll cheerfully refund your money, and you can keep the product.

Unlike other research firms, we believe you should claim your market insights risk-free, because it allows you to put trust our products and our company.

View BioInformant’s global strategic reports for the stem cell industry now.


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>